{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:01:18Z","timestamp":1790438478038,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472002"],"award-info":[{"award-number":["82472002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["NO. 242300420395"],"award-info":[{"award-number":["NO. 242300420395"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.intimp.2026.117304","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T10:31:38Z","timestamp":1787394698000},"page":"117304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Parishin degrades CXCL2 via ubiquitination to limit myeloid-derived suppressor cells and potentiate antitumor immunity after incomplete radiofrequency ablation in hepatocellular carcinoma"],"prefix":"10.1016","volume":"188","author":[{"given":"Wenbo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianchun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117304_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.intimp.2026.117304_bb0010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.5009\/gnl240350","article-title":"Local ablation for hepatocellular carcinoma: 2024 expert consensus-based practical recommendations of the Korean liver Cancer association","volume":"18","author":"Han","year":"2024","journal-title":"Gut Liver"},{"key":"10.1016\/j.intimp.2026.117304_bb0015","doi-asserted-by":"crossref","DOI":"10.1080\/02656736.2024.2331704","article-title":"Radiofrequency ablation of hepatocellular carcinoma guided by real-time physics-based ablation simulation: a prospective study","volume":"41","author":"Hoffer","year":"2024","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.intimp.2026.117304_bb0020","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3348\/kjr.2015.16.6.1226","article-title":"Ultrasound-guided percutaneous radiofrequency ablation of liver tumors: how we do it safely and completely","volume":"16","author":"Kim","year":"2015","journal-title":"Korean J. Radiol."},{"key":"10.1016\/j.intimp.2026.117304_bb0025","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2147\/JHC.S388738","article-title":"Radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder without isolation under contrast-enhanced ultrasound monitoring: a comparative study with long term follow-up","volume":"10","author":"Luo","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.intimp.2026.117304_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12893-025-02778-z","article-title":"Radiofrequency ablation combined with immunotherapy to treat hepatocellular carcinoma: a comprehensive review","volume":"25","author":"Xie","year":"2025","journal-title":"BMC Surg."},{"key":"10.1016\/j.intimp.2026.117304_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/imm.70004","article-title":"Radiofrequency ablation and immunotherapy: orchestrating the immune microenvironment for improved hepatocellular carcinoma control","author":"Yang","year":"2025","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2026.117304_bb0040","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13046-023-02716-y","article-title":"Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation","volume":"42","author":"Shi","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.117304_bb0045","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.32585","article-title":"Eliminating METTL1-mediated accumulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation","volume":"77","author":"Zeng","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2026.117304_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202311244","article-title":"Ultrasmall metal TPZ complexes with deep tumor penetration for enhancing radiofrequency ablation therapy and inducing antitumor immune responses","volume":"20","author":"Zhu","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.intimp.2026.117304_bb0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2147\/JHC.S358539","article-title":"An overview of hepatocellular carcinoma after insufficient radiofrequency ablation","volume":"9","author":"Guo","year":"2022","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.intimp.2026.117304_bb0060","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41419-025-07622-z","article-title":"Oncolytic peptide LTX-315 plus an anti-CTLA-4 antibody induces a synergistic anti-cancer immune response in residual tumors after radiofrequency ablation of hepatocellular carcinoma","volume":"16","author":"Sun","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117304_bb0065","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2147\/JHC.S515779","article-title":"The impact of microwave ablation on recurrence and metastasis of hepatocellular carcinoma: insights from animal studies and cytokine profiling","volume":"12","author":"Wang","year":"2025","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.intimp.2026.117304_bb0070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13046-024-03244-z","article-title":"Cryoablation-induced neutrophil ca(2+) elevation and NET formation exacerbate immune escape in colorectal cancer liver metastasis","volume":"43","author":"Tan","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.117304_bb0075","doi-asserted-by":"crossref","first-page":"524","DOI":"10.21037\/atm-22-1934","article-title":"Development and validation of an eight-gene signature based predictive model to evaluate the prognosis of hepatocellular carcinoma patients: a bioinformatic study","volume":"10","author":"Zhang","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.intimp.2026.117304_bb0080","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.ccell.2024.10.008","article-title":"Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117304_bb0085","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1038\/onc.2016.367","article-title":"CXCL2\/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer","volume":"36","author":"Zhang","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2026.117304_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-023-01337-3","article-title":"PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117304_bb0095","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1111\/cas.13809","article-title":"Chemokine (C-X-C motif) ligand 1 and CXCL2 produced by tumor promote the generation of monocytic myeloid-derived suppressor cells","volume":"109","author":"Shi","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.intimp.2026.117304_bb0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13578-023-01149-6","article-title":"METTL3-mediated m6A methylation regulates ovarian cancer progression by recruiting myeloid-derived suppressor cells","volume":"13","author":"Wang","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.intimp.2026.117304_bb0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-065X.2008.00608.x","article-title":"Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives","volume":"222","author":"Rodr\u00edguez","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2026.117304_bb0110","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","article-title":"MDSC: markers, development, states, and unaddressed complexity","volume":"54","author":"Hegde","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.117304_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.intimp.2026.117304_bb0120","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2021-326259","article-title":"CXCR2 inhibition enables NASH-HCC immunotherapy","volume":"71","author":"Leslie","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2026.117304_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1184014","article-title":"Development of tolerance to chemokine receptor antagonists: current paradigms and the need for further investigation","volume":"14","author":"Grudzien","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117304_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111853","article-title":"Targeting CXCR1\/2: the medicinal potential as cancer immunotherapy agents, antagonists research highlights and challenges ahead","volume":"185","author":"Che","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2026.117304_bb0135","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.biotechadv.2018.04.009","article-title":"Natural scaffolds in anticancer therapy and precision medicine","volume":"36","author":"Mazumder","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.intimp.2026.117304_bb0140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ccell.2024.03.004","article-title":"Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer","volume":"42","author":"Yang","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117304_bb0145","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.117304_bb0150","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.3192","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"Satija","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2026.117304_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/genes10070531","article-title":"SCINA: a semi-supervised subtyping algorithm of single cells and bulk samples","volume":"10","author":"Zhang","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.intimp.2026.117304_bb0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/gene.2015.58","article-title":"Roquin--a multifunctional regulator of immune homeostasis","volume":"17","author":"Schaefer","year":"2016","journal-title":"Genes Immun."},{"key":"10.1016\/j.intimp.2026.117304_bb0165","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.taap.2013.02.019","article-title":"Gastrodin stimulates anticancer immune response and represses transplanted H22 hepatic ascitic tumor cell growth: involvement of NF-\u03baB signaling activation in CD4+ T cells","volume":"269","author":"Shu","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117304_bb0170","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jep.2016.06.057","article-title":"The rhizome of Gastrodia elata Blume - an ethnopharmacological review","volume":"189","author":"Zhan","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2026.117304_bb0175","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-021-01355-1","article-title":"Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin","volume":"20","author":"Cheng","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.117304_bb0180","article-title":"Neutrophils recruited by NKX2-1 suppression via activation of CXCLs\/CXCR2 axis promote lung adenocarcinoma progression","volume":"11","author":"La\u2019ah","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.intimp.2026.117304_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28155766","article-title":"Targeting members of the chemokine family as a novel approach to treating neuropathic pain","volume":"28","author":"Pawlik","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2026.117304_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12935-025-03765-3","article-title":"CXCL2: a key player in the tumor microenvironment and inflammatory diseases","volume":"25","author":"Lv","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.intimp.2026.117304_bb0195","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1152\/ajpendo.00347.2013","article-title":"NF-\u03baB and STAT1 control CXCL1 and CXCL2 gene transcription","volume":"306","author":"Burke","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2026.117304_bb0200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2567.2006.02344.x","article-title":"Lipopolysaccharide induces CXCL2\/macrophage inflammatory protein-2 gene expression in enterocytes via NF-kappaB activation: independence from endogenous TNF-alpha and platelet-activating factor","volume":"118","author":"De Plaen","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2026.117304_bb0205","doi-asserted-by":"crossref","first-page":"32818","DOI":"10.1021\/acsnano.4c11257","article-title":"Dual-synergistic Nanomodulator alleviates Exosomal PD-L1 expression enabling exhausted cytotoxic T lymphocytes rejuvenation for potentiated iRFA-treated hepatocellular carcinoma immunotherapy","volume":"18","author":"Zhu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2026.117304_bb0210","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12951-024-02579-1","article-title":"Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma","volume":"22","author":"Liu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.intimp.2026.117304_bb0215","article-title":"Parishin A-loaded mesoporous silica nanoparticles modulate macrophage polarization to attenuate tendinopathy","volume":"8","author":"Zhu","year":"2023","journal-title":"npj Regener. Med."},{"key":"10.1016\/j.intimp.2026.117304_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109635","article-title":"A prediction model of major complications after radiofrequency ablation for recurrent hepatocellular carcinoma patients","volume":"140","author":"Xu","year":"2021","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.intimp.2026.117304_bb0225","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejrad.2013.12.015","article-title":"Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a long-term follow-up","volume":"83","author":"Huang","year":"2014","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.intimp.2026.117304_bb0230","doi-asserted-by":"crossref","DOI":"10.1080\/02656736.2023.2182748","article-title":"Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder","volume":"40","author":"Meng","year":"2023","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.intimp.2026.117304_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1641443","article-title":"From molecules to medicine: a systematic review of Gastrodia elata\u2019s bioactive metabolites and therapeutic potential","volume":"16","author":"Zhou","year":"2025","journal-title":"Front. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926011513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926011513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:39:04Z","timestamp":1790437144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926011513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":47,"alternative-id":["S1567576926011513"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117304","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parishin degrades CXCL2 via ubiquitination to limit myeloid-derived suppressor cells and potentiate antitumor immunity after incomplete radiofrequency ablation in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117304"}}